XML 76 R83.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCKHOLDERS' EQUITY AND EQUITY INSTRUMENTS (Additional Information) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Equity compensation, additional general disclosures [Abstract]      
Options outstanding (in shares) 887,867 708,746  
Number of options outstanding that are exercisable (in shares) 416,860 446,794  
Compensation expense related to stock-based compensation awards $ 6.3 $ 7.8 $ 5.0
Unrecorded compensation cost related to non-vested awards $ 12.6    
Unrecorded compensation cost, weighted average period of recognition 2 years 2 months 12 days    
Stock options      
Equity compensation, additional general disclosures [Abstract]      
Fair value of options vested $ 0.8 2.7 1.4
Intrinsic value of stock options exercised during the period 0.1 $ 0.1 $ 0.1
Intrinsic value of options outstanding 2.7    
Intrinsic value of options exercisable $ 0.1